Analysis of new drug registration and review in China in 2021
Acta Pharm Sin B
.
2022 Apr;12(4):2127-2128.
doi: 10.1016/j.apsb.2022.02.018.
Epub 2022 Feb 24.
Authors
Hongxi Hu
1
,
Xiaotong Lu
1
,
Huiyan Xu
1
,
Liyun Zhou
1
Affiliation
1
Pharmcube (Beijing) Co., Ltd., Beijing 100020, China.
PMID:
35847501
PMCID:
PMC9279709
DOI:
10.1016/j.apsb.2022.02.018
No abstract available